Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
US Stock Market Move | Storage concept stocks collectively rose in the morning session, with Micron Technology, Inc. (MU.US) rising more than 6%.
When will HUTCHMED (00013) break the "200 billion valuation curse" after the disclosure of commercialized varieties being withdrawn from the market in the annual report?
The International Energy Agency will hold an emergency meeting to discuss releasing strategic oil reserves to address supply disruptions.
US Stock Market Move | Storage concept stocks collectively rose in the morning session, with Micron Technology, Inc. (MU.US) rising more than 6%.
When will HUTCHMED (00013) break the "200 billion valuation curse" after the disclosure of commercialized varieties being withdrawn from the market in the annual report?
The International Energy Agency will hold an emergency meeting to discuss releasing strategic oil reserves to address supply disruptions.
RECOMMEND
Local Policies Experiment With “Lobster” AI Agents Accelerate Into The Agent Era But Security Risks Remain
10/03/2026
Hong Kong And Macau Join Billion‑Level Guidance Fund Initiative Hong Kong Sets Return‑Investment KPI Macau Targets MOP 20 Billion
10/03/2026
Southbound Capital Sells Heavily Yet Hang Seng Tech Advances How Do Fund Managers Interpret It
10/03/2026
